Antipodes Partners’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5M Sell
87,115
-74,101
-46% -$16.5M 0.36% 53
2026
Q1
$36.4M Sell
161,216
-4,112
-2% -$940K 0.7% 43
2025
Q4
$32.3M Buy
165,328
+149,250
+928% +$29.2M 0.68% 45
2025
Q3
$3.19M Buy
+16,078
New +$3.36M 0.07% 63

Other funds holding HON

Antipodes Partners's HON Position: Q2 2026 in Review

Antipodes Partners reduced its Honeywell (HON) stake by 46% in Q2 2026, selling an estimated $16.5M and leaving 87,115 shares worth $19.5M. The position accounts for 0.36% of the portfolio, ranked #53.

Antipodes Partners first reported a position in HON in Q3 2025 and has held it in 4 quarters since. The position peaked at $36.4M in Q1 2026. 2,151 funds tracked by Wall St. Rank hold HON as of Q2 2026.

  • Antipodes Partners held 87,115 shares of Honeywell worth $19.5M as of Q2 2026.
  • Antipodes Partners sold 74,101 Honeywell shares in Q2 2026, an estimated $16.5M.
  • Honeywell made up 0.36% of Antipodes Partners's portfolio in Q2 2026, its #53 holding.
  • Antipodes Partners first reported a position in Honeywell in Q3 2025 and has held it in 4 quarters since.
  • Antipodes Partners's Honeywell position peaked at $36.4M in Q1 2026.
  • 2,151 funds tracked by Wall St. Rank held Honeywell as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.